home / stock / oxfd / oxfd news


OXFD News and Press, Oxford Immunotec Global PLC

Stock Information

Company Name: Oxford Immunotec Global PLC
Stock Symbol: OXFD
Market: NASDAQ
Website: oxfordimmunotec.com

Menu

OXFD OXFD Quote OXFD Short OXFD News OXFD Articles OXFD Message Board
Get OXFD Alerts

News, Short Squeeze, Breakout and More Instantly...

OXFD - Merger Arbitrage Mondays - Bidding Wars And Revised Agreements

Merger activity decreased last week with four new deals announced. Coherent and Aegion receive rival bids. Athene Holding to merge with Apollo Global Management. For further details see: Merger Arbitrage Mondays - Bidding Wars And Revised Agreements

OXFD - Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection

Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection Canada NewsWire OXFORD , United Kingdom and MARLBOROUGH, Ma...

OXFD - Oxford signs MOU with Green Cross Medical for T-SPOT Discovery SARS-CoV-2 kit

Oxford Immunotec (OXFD) announces it has worked with Green Cross Medical Science South Korea (GC MS) to enter into an MOU to market the research use only T-SPOT Discovery SARS-CoV-2 kit in South Korea.Under the agreement, GC MS will market and sell the product with Ox...

OXFD - Oxford Immunotec Enters a Memorandum of Understanding (MOU) with GC MS (Green Cross Medical Science Corp. - South Korea) to Market the T-SPOT® Discovery SARS-CoV-2 Kit, for the Measurement of the T Cell Immune Response to SARS-CoV-2 Infection, in Sou

OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company today announces it has worked with GC MS and MESDIA Co., Ltd. to enter into an MOU to market t...

OXFD - Oxford Immunotec updates T-SPOT COVID-19 test kit with new panel

Oxford Immunotec (OXFD) announces an update to the configuration of its T-SPOT Discovery SARS-CoV-2 kit to include a cross-reactive panel.An additional panel included in the kit contains epitopes of high genetic homology to endemic human coronaviruses (HCoV), and will faci...

OXFD - Oxford Immunotec Updates Their T-SPOT® Discovery SARS-CoV-2 Kit and Include a New Panel to Detect T Cells Reactive to Endemic Coronaviruses

OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today announces an update to the configuration of the T-SPOT Discovery SARS-CoV-2 kit. Th...

OXFD - STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger

NEW YORK, NY / ACCESSWIRE / January 29, 2021 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in N...

OXFD - Oxford Immunotec: PerkinElmer Offer Provides A Fair Exit For Shareholders

Oxford Immunotec will be acquired by PerkinElmer in an all-cash deal for $22/share. The offer represents a c. 28% premium to the previous closing price at time of announcement and implies a c. 5x revenue multiple. This will likely be a solid bolt-on for PerkinElmer considering the...

OXFD - Merger Arbitrage Analysis And Spread Performance - January 17, 2021

HMS Holdings Corp. slips during the week. Fitbit finally draws to a close. Merger arbitrage cash spreads advance again replicating previous week's returns. For further details see: Merger Arbitrage Analysis And Spread Performance - January 17, 2021

OXFD - New Monthly Series Spotlights What 100 Physicians Find to be Critical Needs in Their Battle Against COVID-19

OXFORD, United Kingdom and MARLBOROUGH, Mass., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, announces the launch of 100 Physicians Find , a monthly survey that takes the pulse of on...

Next 10